Article
Identification and Characterization of Small-Molecule Inhibitors to Selectively Target the DFG-in over the DFG-out Conformation of the B-Raf Kinase V600E Mutant in Colorectal Cancer.
Archiv der Pharmazie - 1 Oct 2016
Yao Huixiang, Sun Qun, Zhu Jinshui
Abstract excerpt
V600E is the most common mutation in the B-Raf kinase domain and the B-RafV600E mutant has been recognized as an attractive target of colorectal cancer. Here, the structural dynamics of V600E-induced conformational conversion in the B-Raf activation loop (A-loop) was characterized in detail using a computational simulation strategy. The simulations revealed that the V600E mutation would induce A-loop flipping...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
